Roche ‘deal of the year’ dazzles Swiss market

A jumbo Sfr1.5bn triple trancher from domestic pharmaceutical giant Roche dominated the Swiss franc bond market this week, attracting Sfr2.5bn of orders from across the currency’s investor base and drawing immediate accolades. "This is the deal of the week and the deal of the year. It’s a trade everyone was involved in," said a banker away from the offering.